Search Results - "Liukkonen, T J O"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive? by Raitanen, M-P, Aine, R A T, Kaasinen, E S, Liukkonen, T J O, Kylmälä, T M, Huhtala, H, Tammela, T L J

    “…Urine cytology is the gold standard in the diagnosis and follow-up of bladder cancer. Cytology, however, exhibits variable sensitivity depending on tumour…”
    Get more information
    Journal Article
  2. 2

    Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer by Liukkonen, T J; O, Lipponen, P K, Helle, M, Jauhiainen, K E

    Published in Urolithiasis (01-02-1997)
    “…Immunoreactivity of bcl-2, p53, the epidermal growth factor (EGFr) and Ki-67 (MIB-1) proteins was assessed by immunohistochemistry in 185 patients with…”
    Get full text
    Journal Article
  3. 3

    Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer by LIPPONEN, P. K, LIUKKONEN, T. J. O

    “…Archival biopsy specimens from transitional-cell bladder cancers (n = 222) were analysed immunohisto-chemically for expression of retinoblastoma (Rb) gene…”
    Get full text
    Journal Article